TENAX THERAPEUTICS, INC.·4

Jul 31, 10:46 AM ET

Jebsen Michael B 4

4 · TENAX THERAPEUTICS, INC. · Filed Jul 31, 2017

Insider Transaction Report

Form 4
Period: 2017-07-31
Jebsen Michael B
Chief Financial Officer
Transactions
  • Disposition to Issuer

    common stock

    2017-07-31$0.65/sh+54$3568,146 total

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT